BamSEC and AlphaSense Join Forces
Learn More

Harrow Inc Com

NASDAQ: HROW    
Share price (1/3/25): $36.34    
Market cap (1/3/25): $1.294 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 26 pages Amended and Restated Bylaws of Harrow, Inc. Dated as of September 29, 2023
12/34/56
EX-3.1
from 8-K 41 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.2
from S-3 ~1 page Certificate of Amendment of Amended and Restated Certificate of Incorporation of Imprimis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 6 pages Certificate of Designation of Series B Cumulative Preferred Stock of Harrow Health, Inc. Pursuant to the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Imprimis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Imprimis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-K 4 pages Amended and Restated Certificate of Incorporation of Imprimis Pharmaceuticals, Inc
12/34/56
EX-3.2
from 10-K 29 pages Amended and Restated Bylaws of Imprimis Pharmaceuticals, Inc. a Delaware Corporation Article 1 Offices
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Amended and Restated Certificate of Incorporation of Imprimis Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-Q 2 pages Certificate of Amendment of Certificate of Incorporation of Transdel Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 10 pages Series a Convertible Preferred Stock
12/34/56
EX-3.(II)
from SB-2 8 pages The Corporation
12/34/56
EX-3.(I)
from SB-2 1 page Certificate of Incorporation
12/34/56